Compounder Definition In House Bill May Use Blended Metrics
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA and stakeholders reiterate that volume cannot be the sole measure of whether a compounder should be regulated like a drug manufacturer; Rep. Griffith pitches potentially using it and other indicators to draw the line.